These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 196068)

  • 1. Facilitatory and inhibitory effects of gamma-aminobutyric acid on ganglionic transmission in the sympathetic cardiac nerves of the dog.
    Kimura T; Imamura H; Hashimoto K
    J Pharmacol Exp Ther; 1977 Aug; 202(2):397-403. PubMed ID: 196068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Facilitation of ganglionic transmission by sulpiride: evidence for an inhibitory role of dopamine in the canine sympathetic ganglion.
    Horn PT; Kohli JD; Goldberg LI
    J Pharmacol Exp Ther; 1982 Nov; 223(2):462-8. PubMed ID: 6290639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Presynaptic facilitation by the new nootropic drug nebracetam, of ganglionic muscarinic transmission in the dog cardiac sympathetic ganglion.
    Kushiku K; Ohjimi H; Yamada H; Furukawa T
    Arzneimittelforschung; 1991 Nov; 41(11):1113-8. PubMed ID: 1725696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Possible inhibitory role of endogenous gamma-aminobutyric acid in the nonnicotinic functions of the dog cardiac sympathetic ganglia.
    Kushiku K; Furukawa T
    J Pharmacol Exp Ther; 1985 Jun; 233(3):810-5. PubMed ID: 2861281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of the sympathetic nervous system in the cardiovascular effects of systemically administered gamma-aminobutyric acid.
    Vemulapalli S; Barletta M
    Arch Int Pharmacodyn Ther; 1984 Jan; 267(1):46-58. PubMed ID: 6144293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antagonism of deslanoside-induced cardiotoxicity by combined nicotinic and muscarinic blockade of autonomic ganglia.
    Gillis RA; Jolson H; Thibodeaux H; Levitt B
    J Pharmacol Exp Ther; 1975 Oct; 195(1):126-32. PubMed ID: 241837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Actions of anticholinesterase agents upon ganglionic transmission in the dog.
    Gillis RA; Flacke W; Garfield JM; Alper MH
    J Pharmacol Exp Ther; 1968 Oct; 163(2):277-86. PubMed ID: 4300677
    [No Abstract]   [Full Text] [Related]  

  • 8. Functional studies of right cardiac sympathetic nerves and ganglia in the dog.
    Tollack JL; Grupp G; Farr WC
    Proc Soc Exp Biol Med; 1971 Jul; 137(3):772-5. PubMed ID: 4397797
    [No Abstract]   [Full Text] [Related]  

  • 9. The effects of methoxyflurane on sympathetic ganglionic transmission.
    Pilon RN; Alper MH; Flacke W
    Anesthesiology; 1973 Sep; 39(3):302-7. PubMed ID: 4353903
    [No Abstract]   [Full Text] [Related]  

  • 10. Nicotinic and muscarinic receptors in the cardiac sympathetic ganglia of the dog.
    Fleisch JH; Flacke W; Gillis RA
    J Pharmacol Exp Ther; 1969 Jul; 168(1):106-15. PubMed ID: 4307315
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of theophylline and N6,O2-dibutyryl adenosine 3':5'-monophosphate on sympathetic ganglionic transmission in rats.
    Hsu SY; McIsaac RJ
    J Pharmacol Exp Ther; 1978 Apr; 205(1):91-103. PubMed ID: 204771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of opioid agonists on sympathetic and parasympathetic transmission to the dog heart.
    Musha T; Satoh E; Koyanagawa H; Kimura T; Satoh S
    J Pharmacol Exp Ther; 1989 Sep; 250(3):1087-91. PubMed ID: 2550614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of sympathetic ganglionic neurotransmission by the selective dopamine-1 receptor agonist fenoldopam (SK&F 82526) in the anesthetized dog.
    Shebuski RJ; Fujita T; Smith JM; Kopaciewicz LJ; Blumberg AL; Hieble JP
    J Pharmacol Exp Ther; 1985 Dec; 235(3):735-40. PubMed ID: 2867207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of muscarinic ganglionic stimulation and blockade upon ganglion responses to DMPP and nicotine.
    Graça AS; Hilton JG; Silva AJ
    Arch Int Pharmacodyn Ther; 1970 Aug; 186(2):379-87. PubMed ID: 4331696
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of alpha adrenoceptor and dopamine receptor agonists and antagonists on ganglionic transmission.
    Satoh Y; Kohli JD; Goldberg LI
    J Pharmacol Exp Ther; 1989 Oct; 251(1):253-7. PubMed ID: 2571718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Actions of gamma-aminobutyric acid (GABA) on ganglionic transmission and ganglion cell excitability.
    Adams PR
    Br J Pharmacol; 1975 Mar; 53(3):438P-439P. PubMed ID: 165848
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of neuroactive aminoacids on central mechanisms of vascular regulation].
    Kovalev GV
    Fiziol Zh SSSR Im I M Sechenova; 1978 May; 64(5):702-10. PubMed ID: 658542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The inhibition of ganglionic transmission via presynaptic dopamine DA1 and postsynaptic DA2 receptor activation in the canine cardiac sympathetic ganglia.
    Mukai M; Kushiku K; Yamada H; Yamada K; Dan K; Furukawa T
    J Pharmacol Exp Ther; 1996 Nov; 279(2):822-9. PubMed ID: 8930189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of neuroactivating amino acids on the system activating sympathetic preganglionic neurons].
    Petrov VI
    Fiziol Zh SSSR Im I M Sechenova; 1978 May; 64(5):711-6. PubMed ID: 658543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of gamma-aminobutyric acid on neural regulation of the canine sinus node.
    Neely BH; Hageman GR; James TN
    Am J Physiol; 1983 Feb; 244(2):H266-72. PubMed ID: 6824093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.